viernes, 29 de junio de 2018

Did You Know? | Updated treatment recommendations for latent TB infection

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection | MMWR

Provided by CDC's Office for State, Tribal, Local and Territorial Support

Did You Know?

Doctor talking to a mom and her child

  • CDC has released updated recommendations on the 12-dose regimen for latent tuberculosis (TB) infection that include treatment for children ages 2–11 years, treatment for persons living with HIV/AIDS, and the use of self-administered therapy.
  • Shorter treatment regimens, like the 12-dose regimen, make it easier for patients to finish treatment and result in higher completion rates.  
  • Healthcare providers can learn more about the 12-dose regimen and share patient education materials and medication tracking tools [PDF-155KB] with their patients.

No hay comentarios:

Publicar un comentario